hypermotility


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to hypermotility: Hypermobility, Hypermobility syndrome

hypermotility

 [hi″per-mo-til´ĭ-te]
excessive or abnormally increased motility, as of the gastrointestinal tract.

hypermotility

/hy·per·mo·til·i·ty/ (hi″per-mo-til´ĭ-te) abnormally increased motility, as of the gastrointestinal tract.

hypermotility

[-motil′itē]
an excessive movement of the involuntary muscles, particularly in the GI tract. Compare hypomotility.

hy·per·mo·til·i·ty

(hīpĕr-mō-tili-tē)
Excessive activity of the gastrointestinal tract.
Compare: dumping syndrome

hypermotility

excessive or abnormally increased motility.

gut hypermotility
decreased transit time for the entire alimentary tract.
intestinal hypermotility
is characterized by increase in gut sounds, spasms of pain, e.g. in spasmodic colic in horses and, in some cases, diarrhea.
References in periodicals archive ?
In this case small bowel hypermotility was implicated and may have been a direct effect of neostigmine used at reversal of muscle relaxation.
This assumption is suported by PEARSON (1971), who reports that distention of intestinal segments, enteritis, alterations in intestinal motility, hypomotility or hypermotility, are considered predisposing factors for the development of intussusception in cattle.
Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat.
The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.
Tranzyme is developing TZP-201, a highly potent and selective motilin antagonist, for the treatment of gastrointestinal hypermotility disorders of various origins including chemotherapy-induced diarrhea (CID).
The hypermotility of the rumen, resulting in the reflux of its content, is due to the action of the plants' grayanotoxin on the muscarinic and nicotinic cholinergic receptors (ARMIEN et al.
In addition, the Company's pipeline includes TZP-102 for chronic gastroparesis, TZP-201 for intestinal hypermotility, and TZP-301 for obesity.
Tranzyme is developing first-in-class, mechanism-based therapeutics for post-operative ileus (POI), gastroparesis, obesity, diabetes and intestinal hypermotility.
Kava kava extract, Passiflora extract and a combination of both extracts, administered to mice, caused a significant decrease of the amphetamine-induced hypermotility and significant prolongation of sleeping phase induced by subcutaneous injection of barbiturates.